平衡(能力)
医学
物理疗法
物理医学与康复
脚踝
生活质量(医疗保健)
肌肉力量
骨质疏松症
害怕跌倒
坠落(事故)
平衡试验
考试(生物学)
毒物控制
内科学
伤害预防
外科
古生物学
护理部
环境卫生
生物
作者
M H Tolouei Gilani,Giti Torkaman,Fariba Bahrami,Noushin Bayat
出处
期刊:Games for health journal
[Mary Ann Liebert]
日期:2023-03-20
卷期号:12 (4): 310-322
被引量:4
标识
DOI:10.1089/g4h.2022.0172
摘要
Objective: Muscle strength and balance impairment change the control strategy and increase the probability of falling. This study aimed to investigate the effect of 6-week strength-balance training through virtual reality exergaming (VRE) on muscle strategy during the limits of stability (LOS) test, fear of falling, and quality of life (QOL) in osteoporotic women. Materials and Methods: Twenty volunteer postmenopausal women with osteoporosis were randomly allocated to the VRE (n = 10) and traditional training (TRT as control, n = 10) groups. The VRE and TRT strength-balance training was performed for 6 weeks and three sessions per week. Before and after exercise, the muscle activity (onset time, peak root means square [PRMS]) and hip/ankle activity ratio were assessed by the wireless electromyography system. The muscle activities of the dominant leg were recorded during LOS functional test. The fall efficacy scale and QOL were assessed. Paired t-test was used to compare results within groups, and an independent t-test was used to compare the percentage changes in parameters between the two groups. Results: The VRE improved the onset time and PRMS. The VRE significantly reduced the hip/ankle activity ratio in the LOS test's forward, backward, and right directions (P < 0.05). No significant change was seen in all directions of the LOS functional test in the TRT group (P > 0.05). VRE reduced the fall efficacy scale (P = 0.042). Both VRT and TRT improved the total QOL score (P = 0.010). Conclusion: VRE was more effective in decreasing the onset time and hip/ankle ratio of muscle activation. The VRE is recommended to induce a better ability to reduce the fear of falling and control balance during functional activity in osteoporotic women. Clinical Trial Registration number: IRCT20101017004952N9.
科研通智能强力驱动
Strongly Powered by AbleSci AI